Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Stoke Therapeutics (STOK) Non-cash Items (2021 - 2025)

Stoke Therapeutics has reported Non-cash Items over the past 5 years, most recently at $5.1 million for Q4 2025.

  • For Q4 2025, Non-cash Items fell 74.96% year-over-year to $5.1 million; the TTM value through Dec 2025 reached $5.1 million, down 74.96%, while the annual FY2025 figure was $5.1 million, 74.96% down from the prior year.
  • Non-cash Items for Q4 2025 was $5.1 million at Stoke Therapeutics, down from $20.4 million in the prior quarter.
  • Over five years, Non-cash Items peaked at $65.0 million in Q4 2021 and troughed at $5.1 million in Q4 2025.
  • A 5-year average of $23.9 million and a median of $20.4 million in 2024 define the central range for Non-cash Items.
  • Biggest five-year swings in Non-cash Items: skyrocketed 142.12% in 2024 and later crashed 74.96% in 2025.
  • Year by year, Non-cash Items stood at $65.0 million in 2021, then tumbled by 68.3% to $20.6 million in 2022, then crashed by 59.05% to $8.4 million in 2023, then surged by 142.12% to $20.4 million in 2024, then tumbled by 74.96% to $5.1 million in 2025.
  • Business Quant data shows Non-cash Items for STOK at $5.1 million in Q4 2025, $20.4 million in Q4 2024, and $8.4 million in Q4 2023.